hemophilianewstoday5h
Blood stem-cell gene therapy leads to stable FVIII levels in small study
Gene therapy using modified blood stem cells helped five adults with severe hemophilia A reach therapeutic levels of clotting ...
standard-journal9h
Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
First demonstration of single AAV muscle editing in non-human primates: NanoCas achieved in vivo editing efficiencies of up to 30% when targeting dystrophin in the skeletal muscle of cynomolgus ...
4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population
Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...
Hosted on MSN2d
Ocugen Receives FDA Greenlight for Phase 1 Trial of Mucosal COVID-19 Vaccine
Biopharmaceutical company Ocugen, Inc. (NASDAQ: OCGN) has announced that the U.S. Food and Drug Administration (FDA) has ...
KIOXIA AiSAQ Technology Designed to Reduce DRAM Requirements in Generative AI Systems Released as Open Source Software
KIOXIA AiSAQ Technology Designed to Reduce DRAM Requirements in Generative AI Systems Released as Open Source Software ...
Computer Weekly4d
TCS to inject AI and quantum computing into aerospace through French delivery centre
Indian IT services giant opens IT delivery centre that will focus on technology that can address the challenges of the ...